Table 3.
All patients |
All smokers |
All COPD |
|||||||
---|---|---|---|---|---|---|---|---|---|
Correlation | n | Coeff. | P-value | n | Coeff. | P-value | n | Coeff. | P-value |
CD4+CD28null-FEV1% | 62 | −0·485 | <0·001 | 48 | −0·517 | <0·001 | 34 | −0·317 | 0·068 |
CD4+CD28null-MEF50% | 62 | −0·404 | 0·001 | 48 | −0·479 | <0·001 | 34 | −0·355 | 0·04 |
CD4+CD28null-MEF25% | 62 | −0·38 | 0·002 | 48 | −0·403 | 0·004 | 34 | −0·154 | 0·384 |
IFN-γ-FEV1% | 62 | 0·461 | <0·001 | 48 | 0·613 | <0·001 | 34 | 0·491 | 0·003 |
IFN-γ-MEF50% | 62 | 0·556 | <0·001 | 48 | 0·645 | <0·001 | 34 | 0·541 | <0·001 |
IFN-γ-MEF25% | 62 | 0·489 | <0·001 | 48 | 0·618 | <0·001 | 34 | 0·492 | 0·003 |
TNF-α-FEV1% | 62 | 0·374 | 0·003 | 48 | 0·336 | 0·019 | 34 | 0·226 | 0·198 |
TNF-α-MEF50% | 62 | 0·337 | 0·007 | 48 | 0·275 | 0·058 | 34 | 0·123 | 0·489 |
TNF-α-MEF25% | 62 | 0·309 | 0·014 | 48 | 0·249 | 0·087 | 34 | 0·039 | 0·828 |
IL-1β-FEV1% | 62 | 0·344 | 0·006 | 48 | 0·287 | 0·048 | 34 | 0·066 | 0·709 |
IL-1β-MEF50% | 62 | 0·282 | 0·026 | 48 | 0·256 | 0·079 | 34 | 0·078 | 0·663 |
IL-1β-MEF25% | 62 | 0·266 | 0·037 | 48 | 0·22 | 0·133 | 34 | 0·002 | 0·993 |
IL-10-FEV1% | 62 | 0·256 | 0·044 | 48 | 0·178 | 0·226 | 34 | 0·096 | 0·587 |
IL-10-MEF50% | 62 | 0·328 | 0·009 | 48 | 0·278 | 0·055 | 34 | 0·329 | 0·058 |
IL-10-MEF25% | 62 | 0·3 | 0·018 | 48 | 0·226 | 0·122 | 34 | 0·214 | 0·223 |
FEV1, forced expiratory volume in 1 s; IFN-γ, interferon-γ; IL, interleukin; MEF, maximum expiratory flow; TNF-α, tumour necrosis factor-α.